Distinct Chromosomal Alterations and Differential Expression in Cutaneous T-Cell Lymphomas

Strategic Insights -

Cutaneous anaplastic large cell lymphoma (C-ALCL) and primary cutaneous peripheral T-cell lymphoma not otherwise specified (PTL-NOS) are distinct entities with varying prognoses. A recent study conducted in Leiden, Netherlands, reveals that C-ALCL has an indolent clinical course and favorable prognosis, whereas PTL-NOS shows aggressive behavior. By using array-based comparative genomic hybridization (CGH) analysis and gene expression profiling, researchers identified specific chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators in these cutaneous T-cell lymphomas.

Key Takeaways:

  • C-ALCL and PTL-NOS have distinct chromosomal alterations, with C-ALCL characterized by gains on chromosome 7q and 17q, and losses on 6q and 13q, while PTL-NOS shows gains on 7q and 17q, and gains on chromosome 8 and loss of a focal overlapping region on 9p21.
  • C-ALCL showed higher expression of skin-homing chemokine receptor genes CCR10 and CCR8, which may explain the lower tendency of dissemination to extracutaneous sites.
  • PTL-NOS showed aberrant expression of distinct genes implicated in apoptosis and proliferation, such as IRF4/MUM1 and PRKCQ, which may account for differences in clinical aggressiveness.
  • The researchers identified minimal common regions harboring candidate oncogenes and tumor suppressor genes in C-ALCL and PTL-NOS.
  • The study highlights the complexity of cutaneous T-cell lymphomas and the need for further research to understand the underlying mechanisms of these diseases.

Statistics:

  • 7q and 17q chromosomal gains were observed in both C-ALCL and PTL-NOS (Journal of Investigative Dermatology).
  • 6q and 13q chromosomal losses were observed in C-ALCL.
  • 8p chromosomal gain was observed in PTL-NOS.
  • 9p21 focal overlapping region loss was observed in PTL-NOS.
  • C-ALCL showed higher expression of CCR10 and CCR8 genes compared to PTL-NOS.
  • IRF4/MUM1 and PRKCQ genes were aberrantly expressed in PTL-NOS.

Sources:

  • Journal of Investigative Dermatology, vol. 130, no. 2, pp. 563-75 (2010).
  • Kester M.S. van and colleagues, University Medical Center, Department of Dermatology, Leiden, Netherlands.